Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data
- 19 April 2007
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 18 (5) , 561-569
- https://doi.org/10.1007/s10552-007-0131-1
Abstract
Claims data may be a suitable source studying associations between drugs and cancer. However, linkage between cancer registry and claims data including pharmacy-dispensing information is not always available. We examined the accuracy of claims-based definitions of incident cancers and their date of diagnosis.Keywords
This publication has 15 references indexed in Scilit:
- Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- The Added Value of Claims for Cancer SurveillanceMedical Care, 2005
- Using Hospital Discharge Files to Enhance Cancer SurveillanceAmerican Journal of Epidemiology, 2003
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- Finding incident breast cancer cases through US claims data and a state cancer registry.Cancer Causes & Control, 2001
- National Cancer Data Base/Surveillance Epidemiology and End Results: Potential Insensitive-Measure BiasGynecologic Oncology, 2000
- Cancer Occurrence in the ElderlyAnnals of Epidemiology, 1999
- Patients with Newly Diagnosed Carcinoma of the Breast Validation of a Claim-based Identification AlgorithmJournal of Clinical Epidemiology, 1999
- Ability of Medicare Claims Data and Cancer Registries to Identify Cancer Cases and TreatmentAmerican Journal of Epidemiology, 1997
- Analysis of a claims database for the identification of patients with carcinoma of the breastJournal of Medical Systems, 1994